.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Julphar
Cerilliant
UBS
Healthtrust
Chubb
US Army
QuintilesIMS
Express Scripts
Queensland Health

Generated: June 24, 2017

DrugPatentWatch Database Preview

HEPARIN SODIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Heparin Sodium, and when can generic versions of Heparin Sodium launch?

Heparin Sodium is a drug marketed by Hospira, Sandoz, Eurohlth Intl Sarl, Solopak, Watson Labs Inc, Sagent Pharms, Lilly, Gland Pharma Ltd, Fresenius Kabi Usa, Chamberlin Parenterl, Abraxis Pharm, Shenzhen Techdow, West-ward Pharms Int, Smith And Nephew, Dell Labs, Parke Davis, Luitpold, Organon Usa Inc, Watson Labs, Pfizer, Pharmacia And Upjohn, Hospira Inc, Pharm Spec, Akorn, Baxter Hlthcare, Mcgaw, B Braun, and Pharma Serve Ny. and is included in fifty-eight NDAs.

The generic ingredient in HEPARIN SODIUM is heparin sodium. There are seventy-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

Summary for Tradename: HEPARIN SODIUM

Patents:0
Applicants:28
NDAs:58
Suppliers / Packagers: see list12
Clinical Trials: see list2,983
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HEPARIN SODIUM at DailyMed

Pharmacology for Tradename: HEPARIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
HEPARIN SODIUM
heparin sodium
INJECTABLE;INJECTION201370-001Jul 21, 2011RXYesYes► Subscribe► Subscribe
Hospira
HEPARIN SODIUM
heparin sodium
INJECTABLE;INJECTION088099-001Apr 28, 1983DISCNNoNo► Subscribe► Subscribe
Dell Labs
HEPARIN SODIUM
heparin sodium
INJECTABLE;INJECTION017540-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Shenzhen Techdow
HEPARIN SODIUM
heparin sodium
INJECTABLE;INJECTION202733-001Jun 12, 2014APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
HEPARIN SODIUM PRESERVATIVE FREE
heparin sodium
INJECTABLE;INJECTION017029-019Nov 22, 2010RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Fish and Richardson
Chubb
Merck
Moodys
Cipla
Cerilliant
Novartis
UBS
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot